NEW YORK--(BUSINESS WIRE)--Viramal, (“the Company”), an emerging specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, today announced the appointment of William Bologna as Chairman of the Board of Directors, effective immediately. Mr. Bologna is also the Company’s chief scientist.
